Share Twitter LinkedIn Facebook Email Steven Chang, M.D., M.S. Urologic Oncologist and Health Service Researcher at Brigham and Women’s Hospital discusses Should We Be Doing Robotic Radical Nephrectomy at the Seventeenth International Kidney Cancer Symposium on Nov 2, 2018.
VIDEO: FDA Approves Atezolizumab / Tecentriq Hybreza For Subcutaneous PD-(L)1 Cancer Immunotherapy in NSCLC Kidney 4 Mins Read
Nivolumab Combo Phase 3 TiNivo 2 Results + Tivozanib in RCC Presented at ESMO 2024: AVEO Kidney 4 Mins Read
Impact of Latino Ethnicity on Gut Microbiome in mRCC: ASCO 2024 Study – Regina Barragan-Carillo, Phd – City of Hope ASCO Annual Meeting 2 Mins Read